Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations

Figure 2

The time from randomization to first hemoglobin >12 g/dL in patients who received 1500 mg IV iron and patients who received 1000 mg from Study 7, . Day 56 is the last study visit, and at the discretion of the investigator, patients were allowed to be retreated with additional IV iron between Days 56 and 90. Data on file, Luitpold Pharmaceuticals, Inc.